Alkermes, Inc. (ALKS) Posts Wider than Expected Q1 Loss
Get Alerts ALKS Hot Sheet
Price: $45.34 -0.07%
Revenue Growth %: +17.5%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: +17.5%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Alkermes, Inc. (NASDAQ: ALKS) reported Q1 loss of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $61.9 million versus the consensus estimate of $52.67 million.
Alkermes reported pro forma EPS during the quarter of $0.02, excluding one-time items and share-based compensation expense, compared to a pro forma loss per share of ($0.09) last year.
Alkermes reported pro forma EPS during the quarter of $0.02, excluding one-time items and share-based compensation expense, compared to a pro forma loss per share of ($0.09) last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alkermes starts phase 2 trial of ALKS 7290 for depression
- Alkermes Expands ALKS 7290 Development Program With Initiation of Phase 2 Study for the Adjunctive Treatment of Major Depressive Disorder (MDD)
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share